Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics.
about
Effect of atypical antipsychotics on fetal growth: is the placenta involved?Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research.Assessment of cytochrome C oxidase dysfunction in the substantia nigra/ventral tegmental area in schizophrenia.Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanismsPharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update.Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naïve schizophrenia.Agmatine protection against chlorpromazine-induced forebrain cortex injury in rats.N-acetylaspartate reduction in the medial prefrontal cortex following 8 weeks of risperidone treatment in first-episode drug-naïve schizophrenia patientsOrganochalcogens inhibit mitochondrial complexes I and II in rat brain: possible implications for neurotoxicity.Drugs interfering with mitochondrial disorders.A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.Connectivity between mitochondrial functions and psychiatric disorders.Postmortem studies on mitochondria in schizophrenia.Antipsychotic-induced DRD2 upregulation and its prevention by α-lipoic acid in SH-SY5Y neuroblastoma cells.Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.Effects of agmatine on chlorpromazine toxicity in the liver of Wistar rats: the possible role of oxidant/antioxidant imbalance.Quetiapine, olanzapine and haloperidol affect human plasma lipid peroxidation in vitro.Protective Effect of Leaves of Murraya koenigii on Reserpine-Induced Orofacial Dyskinesia.Mitochondrial complex I and III gene mRNA levels in schizophrenia, and their relationship with clinical features.Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid.Oxidized low-density lipoprotein and 15-deoxy-delta 12,14-PGJ2 increase mitochondrial complex I activity in endothelial cells.[3H]BHDP as a novel and selective ligand for sigma1 receptors in liver mitochondria and brain synaptosomes of the rat.Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease.Effect of antipsychotics on creatine kinase activity in rat brain.Risperidone Attenuates Modified Stress-Re-stress Paradigm-Induced Mitochondrial Dysfunction and Apoptosis in Rats Exhibiting Post-traumatic Stress Disorder-Like Symptoms.Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis.Antioxidant effects of rice bran oil mitigate repeated haloperidol-induced tardive dyskinesia in male rats.Ultrastructural abnormalities of astrocytes in the hippocampus in schizophrenia and duration of illness: a postortem morphometric study.MK-801 alters Na+, K+-ATPase activity and oxidative status in zebrafish brain: reversal by antipsychotic drugs.Drug-Induced Mitochondrial Toxicity.
P2860
Q27012948-A5797EE7-2607-4A54-9F51-8155973E300BQ30995022-BFBB6C7F-05A1-434A-9CCB-845313CB75CCQ33773639-E2886FD7-B3CA-48F0-B822-1B423743B488Q35044374-80669FC3-E32E-40CA-BE4B-A6D98E349F88Q35771833-FBA930CB-0D39-4428-972A-12C749B20103Q36382608-030F99CB-57A3-4E78-BFD7-4D03B5E21C35Q36731453-AD0A96BA-816F-413B-AD06-78B976A8E97AQ36972662-3895E07E-F33B-473C-80DD-8EBC82BF1FFFQ37601925-709EC06D-D75F-48C1-9140-24D8D598D96BQ37617357-7B3009C9-F08A-4012-A05F-8531209EFCF8Q37705728-31791DC3-AE82-411D-8CA4-838CB5389689Q37854101-17630A28-E96E-48C3-86D8-5B26D366BF4AQ39131756-895EE78A-A5FE-4115-B4B7-CF4D3C69E97DQ39664514-BB560FC7-3B9E-4185-83D1-8D84D20CB56BQ41927221-88D184A1-8894-446E-B67C-7479DF223DF6Q42322622-28AD15C9-8E45-48C3-A6FA-01DF83AFA780Q42745478-6F60F37E-C59D-4963-8ED9-8A8969759432Q42880698-3F611F94-04DE-4174-8A62-BC625A11A3CCQ43120378-201FCFA0-4CD5-4B1E-AB0D-170C0F24CB7EQ44386044-C2FD35DD-B9D6-4BBB-AB1C-C84150CFACB2Q44525843-D18E16F6-BEB7-4F4F-A64E-8585D86ECABBQ44612505-08D25F42-8862-4852-A2F1-AC29FEBDD970Q46322181-BB02FAAA-83CC-499E-90AC-14B5E068A6DAQ46970965-A87DF1AE-C437-466D-BCE6-1D556ED9358AQ47738847-1FB6CC08-4BD5-4308-8BA3-26386755F1A4Q47890327-61242151-79AB-4772-BE10-9ACCFCC6D58BQ48231614-32B86634-16E2-48B7-B0B5-178D031B03AFQ48664746-0563545B-8B9C-4A44-9C35-EB5346DC3E29Q48798503-960067EF-C0D0-42EC-9BD4-C601867332EEQ51538858-0683D229-A338-45A7-98B9-035FDFCD5E3D
P2860
Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Protein thiol oxidation by hal ...... with atypical antipsychotics.
@ast
Protein thiol oxidation by hal ...... with atypical antipsychotics.
@en
type
label
Protein thiol oxidation by hal ...... with atypical antipsychotics.
@ast
Protein thiol oxidation by hal ...... with atypical antipsychotics.
@en
prefLabel
Protein thiol oxidation by hal ...... with atypical antipsychotics.
@ast
Protein thiol oxidation by hal ...... with atypical antipsychotics.
@en
P2093
P1476
Protein thiol oxidation by hal ...... with atypical antipsychotics.
@en
P2093
Balijepalli S
Kenchappa RS
Ravindranath V
P304
P356
10.1016/S0197-0186(00)00108-X
P577
2001-04-01T00:00:00Z